MARC状态:审校 文献类型:西文图书 浏览次数:6
- 题名/责任者:
- Biologics and biosimilars : drug development and clinical affairs / edited by Xiaodong Feng, Hong-Guang Xie, Ashim Malhotra, Catherine F. Yang.
- 版本说明:
- First edition.
- 出版发行项:
- Boca Raton, FL : Taylor and Francis, 2022.
- ISBN:
- 9781138594227
- ISBN:
- 1138594229
- ISBN:
- 9781032262024
- ISBN:
- 1032262028
- 载体形态项:
- xviii, 510 pages : illustrations ; 26 cm
- 附加个人名称:
- Feng, Xiaodong, editor.
- 附加个人名称:
- Xie, Hong-Guang, editor.
- 附加个人名称:
- Malhotra, Ashim, 1977- editor.
- 附加个人名称:
- Yang, Catherine F., editor.
- 论题主题:
- Drug development.
- 中图法分类号:
- R918
- 书目附注:
- Includes bibliographical references and index.
- 内容附注:
- Biologics and Biosimilars 101: Principles and Practice -- Frontiers in Biopharmaceutical Development of Biologics and Biosimilars: Opportunities and Challenges -- Biologics and Biosimilars: Research and Development -- Vaccines as Biologics in the Era of Pandemic -- Therapeutic Delivery Systems for Biologics and Biosimilars -- Legislative and Regulatory Pathways for Biosimilars -- The Development of Biologics from the Perspective of the Pharmaceutical Industry -- The Manufacturing and Quality Assurance Process for Biologics and Biosimilars -- Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics of Biological Products -- Understanding Variability, Stability, and Immunogenicity of Biosimilars -- Expanding the Product Shelf: Taking Biologics and Biosimilars from the Bench to the Bedside -- Hydrogel-Based Delivery of Biologics in Cancer and Cardiovascular Diseases: Proof-of-Concept -- Clinical Use of Biologics and Biosimilars in Oncology Settings -- Monoclonal Antibodies in Cancer Therapeutics -- Molecule-Targeted Drugs That Treat Colorectal Cancer -- Rising from the Ashes: The Curious Case of the Development of Biologics for the Treatment of Neuroblastoma -- Paradigm Shift in Cancer Therapy: Chimeric Antigen Receptor T Cell Therapy -- Biologics and Biosimilars Used for Diabetes -- Clinical Use of Biologics and Biosimilars in Asthma -- Biologics and Biosimilars: Potential Therapeutics for Autoimmune Renal Diseases -- Therapeutics of Recombinant Human Clotting Factor VIII (rhFVIII) for Hemophilia A -- Complement as New Immunotherapy Target: Past, Present, and Future -- Drug Discovery Approaches for Inflammatory Bowel Disease: Antibodies and Biosimilars -- Transformative Stem Cell-Based Therapy in Neurological Diseases and Beyond -- Biologics and Biosimilars: Clinical Applications and Biomarker Testing -- Application of Modeling and Simulation in the Development of Biologics and Biosimilars -- Machine Learning Applications in Biologics and Biosimilars: Disruptive Innovation.
- 摘要附注:
- "Biologics and Biosimilars: Drug Development and Clinical Affairs is a systematic integration and evaluation of all aspects of biologics and biosimilars, R&D and clinical use, global regulation, and more"--
全部MARC细节信息>>